BIOSU — BioPlus Acquisition Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsAdventurousSmall Cap

Annual balance sheet for BioPlus Acquisition, fiscal year end - December 31st, millions except per share.

	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—
Source:		10-K	10-K
Standards:	—	USG	USG
Status:	fx Preliminary	Final	Final
Cash
Cash and Short Term Investments	—	0.636	0.14
Prepaid Expenses
Total Current Assets	—	1	0.549
Long Term Investments
Other Long Term Assets
Total Assets	—	236	238
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	—	0.179	0.527
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	—	15	15.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	—	221	223
Total Liabilities & Shareholders' Equity	—	236	238
Total Common Shares Outstanding